Thymus Regeneration In Countering Immunosenescence: Mechanisms, Strategies And Future Perspectives
As we age, our immune system naturally declines, a process called immunosenescence. This makes us more vulnerable to infections, reduces the effectiveness of vaccines, and contributes to chronic inflammation throughout the body. A key player in this age-related decline is the thymus, a small organ located in the chest. The thymus is responsible for producing a crucial type of immune cell called T cells, specifically “naive T cells” that are like the immune system’s scouts, ready to identify and fight off new threats. However, with age, the thymus shrinks and becomes less functional, a process known as thymic involution. This leads to a shortage of new T cells and a less diverse immune response, leaving older adults with an immune system that struggles to adapt to new pathogens. Restoring the function of the thymus, or “thymic regeneration,” is therefore seen as a promising way to rejuvenate the immune system and combat the effects of aging. Researchers are exploring various approaches to achieve this, including therapies that involve growth hormones, specific immune signaling molecules (cytokines), medications that target cellular growth pathways (mTOR inhibitors), and even advanced techniques like stem cell therapies, gene therapy, and tissue engineering to rebuild or enhance thymic function.
Source: link to paper